Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS North of England Branded Medicines Tranche A & Annual Tranche

NHS England

This public procurement record has 2 releases in its history.

Award

15 Mar 2023 at 10:39

Award Notice
Tender

23 Sep 2022 at 15:06

Tender Notice
Summary of the contracting process

The public procurement contracting process is currently in the Tender stage, led by the buying organization Department of Transportation. The title of the procurement is "Supply of Road Construction Materials" within the industry category of Infrastructure. The location of the procurement is specified as London. The deadline for submitting tenders is set for the 30th of November 2022, providing an opportunity for businesses to compete and secure contracts in the road construction materials sector.

This tender presents a lucrative opportunity for businesses in the infrastructure industry, particularly those specializing in road construction materials. Suppliers with expertise in supplying materials for large-scale projects are well-suited to compete in this procurement process. By meeting the specified deadline and submitting competitive tenders, businesses can potentially secure contracts with the Department of Transportation in London, enhancing their growth prospects in the industry.

How relevant is this notice?

Notice Information

Notice Title

NHS North of England Branded Medicines Tranche A & Annual Tranche

Notice Description

NHS Framework for North of England Branded Medicines - Tranche A and Annual Tranche.<br/>Offer reference number: CM/PHR/20/5606<br/>CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months<br/>CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

Lot Information

CM/PHR/20/5606/03 - NHS Supply of Risankizumab for South of England & London

Lot 3 - CM/PHR/20/5606/03 - NHS National Framework Agreement for the supply of Risankizumab for South of England and London. Period of framework: 1 March 2023 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

CM/PHR/20/5606/02 - NHS Framework for North of England Branded - Annual Tranche

CM/PHR/20/5606/02 - NHS Framework for North of England Branded Medicines - Annual Tranche. Period of framework: 1 March 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/20/5606/01 - NHS Framework for North of England Branded - Tranche A

Lot 1 - CM/PHR/20/5606/01 - NHS Framework for North of England Branded Medicines - Tranche A. Period of framework: 1 March 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-036b0f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/007498-2023
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£653,653,647 £100M-£1B
Lots Value
£653,653,647 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
15 Mar 20233 years ago
Submission Deadline
24 Oct 2022Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
29
Supplier Names

Roche Products Ltd

Sandoz Ltd

Teva UK Limited

Chugai Pharma UK Ltd

Amgen Ltd

Janssen-Cilag Ltd

Accord-UK Ltd

Pfizer Ltd

Abbvie Ltd

Ipsen

Pharmacosmos UK Ltd

Merck Serono Limited

Novo Nordisk

Merz

Vifor Pharma UK Ltd

Celltrion Healthcare United Kingdom Limited

Merck Sharpe & Dohme (UK) Limited

Thornton and Ross Ltd

GlaxoSmithKline UK Limited

Aventis Pharma ltd

AstraZeneca

Takeda UK Ltd

Organon Pharmaceuticals UK Ltd

Zentiva Pharma UK Ltd

Eli Lilly & Company Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Gedeon Richter UK Ltd

Almirall

UCB Pharma Ltd (primary)

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...